etoposide has been researched along with Tinnitus in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Daoud, J; Elloumi, F; Fourati, N; Frikha, M; Ghorbel, A; Ghorbell, L; Jlidi, R; Siala, W | 1 |
Bremnes, RM; Brydøy, M; Fosså, SD; Gundersen, POM; Haugnes, HS; Hjelle, LV; Oldenburg, J; Sprauten, M; Tandstad, T; Wilsgaard, T | 1 |
Abu Zaid, M; Althouse, S; Ardeshir-Rouhani-Fard, S; Beard, CJ; Cook, R; Einhorn, LH; Feldman, DR; Fossa, SD; Fung, C; Hamilton, RJ; Kerns, SL; Kollmannsberger, CK; Lipshultz, SE; Monahan, P; Sesso, HD; Travis, LB; Vaughn, DJ; Williams, AM | 1 |
Anderson, D; Leonetti, JP; Marzo, S; Shirazi, MA | 1 |
4 other study(ies) available for etoposide and Tinnitus
Article | Year |
---|---|
[Large cell neuroendocrine carcinoma of the nasopharynx: A case report].
Topics: Adult; Antineoplastic Agents; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Fatal Outcome; Humans; Male; Meningeal Neoplasms; Nasal Obstruction; Nasopharyngeal Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Tinnitus | 2014 |
Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Survivors; Carboplatin; Cardiovascular Diseases; Cisplatin; Combined Modality Therapy; Comorbidity; Etoposide; Follow-Up Studies; Hearing Loss; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Norway; Orchiectomy; Peripheral Nervous System Diseases; Surveys and Questionnaires; Testicular Neoplasms; Tinnitus; Vinblastine; Young Adult | 2016 |
Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Canada; Case-Control Studies; Cisplatin; Etoposide; Exercise; Health Status; Hearing Loss; Humans; Long Term Adverse Effects; Male; Middle Aged; Obesity; Peripheral Nervous System Diseases; Prevalence; Protective Factors; Raynaud Disease; Risk Factors; Smoking; Surveys and Questionnaires; Survivors; Testicular Neoplasms; Tinnitus; United States; Young Adult | 2017 |
Neuroendocrine carcinoma of the jugular foramen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Ataxia; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Diagnosis, Differential; Etoposide; Female; Headache; Hearing Loss, Sensorineural; Humans; Jugular Veins; Magnetic Resonance Imaging; Middle Aged; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Skull Base Neoplasms; Tinnitus; Vertigo | 2008 |